[1]Lam Q L, Lu L.Role of leptin in immunity[J].Cell Mol Immunol, 2007, 4(1):1-13[2]Davidovici B B, Sattar N, Prinz J, et al.Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions[J].J Invest Dermatol, 2010, 130(7):1785-1796[3]Xue K, Liu H, Jian Q, et al.Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro--a possible reason for increased severity of psoriasis in patients with a high body mass index[J].Exp Dermatol, 2013, 22(6):406-410[4]Leigh I M, Navsaria H, Purkis P E, et al.Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro[J].Br J Dermatol, 1995, 133(4):501-511[5]王刚, 刘玉峰.治疗银屑病的一个新的药物作用靶标——角蛋白[J].中国皮肤性病学杂志, 2005, 19(12):753-754[6]张巍, 史晓蔚, 呼蕾, 等.白介素调控角质形成细胞表达角蛋白的研究[J].临床皮肤科杂志, 2011, 40(4):199-202[7]Chen Y J, Wu C Y, Shen J L, et al.Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome[J].Arch Dermatol, 2008, 144(12):1571-1575[8]Wang Y, Chen J, Zhao Y, et al.Psoriasis is associated with increased levels of serum leptin[J].Br J Dermatol, 2008, 158(5):1134-1135[9]Cerman A A, Bozkurt S, Sav A, et al.Serum leptin levels,skin leptin and leptin receptor expression in psoriasis[J].Br J Dermatol, 2008, 159(4):820-826[10]Gudmundsdottir A S, Sigmundsdottir H, Sigurgeirsson B, et al.Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?[J].Clin Exp Immunol, 1999, 117(3):580-586[11]Valdimarsson H, Sigmundsdottir H, Jonsdottir I.Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin?[J]. Clin Exp Immunol, 1997, 107 Suppl 1:21-24.[12]Sigmundsdottir H, Sigurgeirsson B, Troye-Blomberg M, et al.Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins[J].Scand J Immunol, 1997, 45(6):688-697[13]Goren I, Pfeilschifter J, Frank S.Determination of leptin signaling pathways in human and murine keratinocytes[J].Biochem Biophys Res Commun, 2003, 303(4):1080-1085[14]Miyoshi K, Takaishi M, Nakajima K, et al.Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21,a Stat3 inhibitor[J].J Invest Dermatol, 2011, 131(1):108-117 |